medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 22, 2024
Abstract
Bimodal
neuromodulation
combining
sound
therapy
with
electrical
tongue
stimulation
using
the
Lenire
device
is
emerging
as
an
effective
treatment
for
tinnitus.
A
single-arm
retrospective
chart
review
analyzes
real-world
outcomes
220
tinnitus
patients
from
Alaska
Hearing
and
Tinnitus
Center
recently
FDA-approved
first
time
in
a
United
States
clinic.
The
primary
endpoint
examines
responder
rate
mean
change
Handicap
Inventory
(THI)
after
approximately
12
weeks
of
eligible
moderate
or
worse
represents
THI
improvement
greater
than
seven
points
(i.e.,
minimal
clinically
important
difference,
MCID).
Of
212
available
data,
there
was
high
91.5%
(95%
CI:
86.9%,
94.5%)
27.8
±
1.3
(SEM)
points,
no
device-related
serious
adverse
events.
Furthermore,
MCID
consistent
criterion
clinical
benefit
based
on
evidence.
Journal of Medical Internet Research,
Год журнала:
2024,
Номер
27, С. e59575 - e59575
Опубликована: Дек. 23, 2024
Background
Tinnitus
is
the
perception
of
sound
without
an
external
auditive
stimulus
and
can
be
a
severe
burden
for
affected
patients.
Medical
guidelines
recommend
cognitive
behavioral
therapy
(CBT)
tinnitus
treatment,
which
effectively
improves
tinnitus-related
distress
anxiety.
Objective
This
study
investigates
outcome
9-month
smartphone-based
CBT
patients
with
tinnitus.
Methods
The
randomized
controlled
clinical
trial
in
this
efficacy
187
chronic
over
treatment
period.
In
initial
3
months,
waiting
list
design
was
applied,
subsequent
phase,
data
both
groups
were
collectively
analyzed.
scores
on
Questionnaire
(TQ);
9-item
Patient
Health
(PHQ-9);
Self-Efficacy,
Optimism,
Pessimism
(SWOP-K9)
questionnaire;
20-item
Perceived
Stress
(PSQ-20)
assessed
as
endpoints
after
9
months
treatment.
Results
We
observed
statistically
significant
reduction
who
received
intervention.
Although
no
changes
initially
TQ
sum
control
group
(baseline
mean,
37.8,
SD
4.7;
mean
37.5,
4.8;
analysis
covariance
[ANCOVA]
P=.52),
significantly
decreased
once
app-based
had
commenced.
Data
pooled
from
revealed
score
by
12.49
(SD
1.44)
(ANCOVA,
P<.001)
18.48
1.85)
points
respectively,
also
clinically
important.
calculated
Cohen
d
1.38.
Similarly,
PSQ-20
(–9.14
points;
ANCOVA,
P<.001),
PHQ-9
(–2.47
SWOP-K9
(0.17
improved
at
end
therapy,
corresponding
intermediate
effect
sizes
months.
Conclusions
our
provide
evidence
significant,
relevant,
continuous
benefits
intervention
Trial
Registration
Deutsches
Register
Klinischer
Studien
DRKS00022973;
https://drks.de/search/de/trial/DRKS00022973
Telemedicine Journal and e-Health,
Год журнала:
2023,
Номер
30(2), С. 307 - 320
Опубликована: Авг. 11, 2023
The
use
of
telerehabilitation
for
the
treatment
speech
and
language
disorders
in
field
hearing
is
increasing.
A
comprehensive
study
comparing
telerehabilitation's
effectiveness
with
traditional
rehabilitation
can
help
us
understand
it
better.
Therefore,
this
systematic
review
aimed
to
compare
children
disabilities
2023.
Journal of Personalized Medicine,
Год журнала:
2024,
Номер
14(8), С. 813 - 813
Опубликована: Июль 31, 2024
Tinnitus
presents
a
major
public
health
challenge,
impacting
quality
of
life.
With
conventional
therapies
being
often
time-consuming
and
costly,
interest
in
Internet-based
treatments,
such
as
auditory
treatments
cognitive
behavioral
therapy,
has
grown
due
to
their
improved
patient
adherence.
This
meta-analysis
aims
review
existing
scientific
literature
assess
the
effectiveness
(IBTs)
treating
tinnitus.
Audiology and Speech Research,
Год журнала:
2024,
Номер
20(4), С. 217 - 227
Опубликована: Окт. 31, 2024
Purpose:
This
study
aimed
to
evaluate
the
efficacy
of
tinnitus
counseling
in
improving
symptoms
among
hearing-impaired
individuals
who
use
hearing
aids
and
have
reported
difficulties
due
tinnitus.Methods:
Thirty
participants
completed
handicap
inventory
(THI),
magnitude
index
(TMI),
a
knowledge
questionnaire
both
before
after
rehabilitation
counseling.
A
tinnitogram
was
also
assessed.
The
customized
based
on
preliminary
survey
that
identified
participants’
misconceptions
or
specific
areas
interest
regarding
tinnitus,
enabling
targeted
informative
counseling.Results:
THI
scores
showed
statistically
significant
decrease,
from
mean
48.16
(standard
deviation
[SD],
27.1)
41.66
(SD,
25.6),
with
an
average
reduction
6.5
points
(<i>p</i>
=
0.000).
Similarly,
TMI
reduction,
20.7
6.1)
19.0
6.58),
decrease
1.7
0.01).Conclusion:
findings
support
alleviating
tinnitus-related
discomfort
used
for
over
year.
While
significant,
analysis
minimum
clinically
difference
only
33%
exhibited
meaningful
improvement.
Future
studies
should
explore
benefits
continuous
those
do
not
respond
single
session.
BACKGROUND
Tinnitus
is
the
perception
of
sound
without
an
external
auditive
stimulus
and
can
be
a
severe
burden
for
affected
patients.
Cognitive
Behavioral
Therapy
(CBT)
recommended
by
medical
guidelines
effectively
improves
tinnitus
related
distress
anxiety.
OBJECTIVE
The
study
investigated
outcome
9
months
smartphone-based
CBT
in
patients
suffering
from
tinnitus.
METHODS
present
randomized
controlled
clinical
trial
efficacy
187
chronic
over
9-months
treatment
period.
In
initial
3
waiting-list
design
was
applied
subsequent
phase
data
both
groups
were
collectively
analyzed.
Questionnaire
(TQ),
Patients
Health
(PHQ9),
Self-Efficacy-Optimism-Pessimism
(SWOP-K9),
Perceived-Stress-Questionnaire
(PSQ20)
assessed
as
endpoints
after
treatment.
RESULTS
Following
app-based
CBT,
TQ
sum
scores
significantly
reduced,
indicating
significant
decrease
tinnitus-related
distress.
calculated
Cohen’s
d
1.38
observed
improvement
also
exceeded
minimal
clinically
important
difference.
Similarly,
all
other
parameters
PSQ20
(-9.14
points),
PHQ9
(-2.47
points)
SWOP-K9
(0.17
improved
at
end
therapy
with
corresponding
intermediate
effect
sizes
months.
revealed
reduction
who
received
CBT.
reduced
12.49
±
1.44
18.48
1.85
points
months,
respectively,
whereby
important.
CONCLUSIONS
provide
evidence
substantial
continuous
benefit
CLINICALTRIAL
DRKS-ID:
DRKS00022973
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 22, 2024
Abstract
Bimodal
neuromodulation
combining
sound
therapy
with
electrical
tongue
stimulation
using
the
Lenire
device
is
emerging
as
an
effective
treatment
for
tinnitus.
A
single-arm
retrospective
chart
review
analyzes
real-world
outcomes
220
tinnitus
patients
from
Alaska
Hearing
and
Tinnitus
Center
recently
FDA-approved
first
time
in
a
United
States
clinic.
The
primary
endpoint
examines
responder
rate
mean
change
Handicap
Inventory
(THI)
after
approximately
12
weeks
of
eligible
moderate
or
worse
represents
THI
improvement
greater
than
seven
points
(i.e.,
minimal
clinically
important
difference,
MCID).
Of
212
available
data,
there
was
high
91.5%
(95%
CI:
86.9%,
94.5%)
27.8
±
1.3
(SEM)
points,
no
device-related
serious
adverse
events.
Furthermore,
MCID
consistent
criterion
clinical
benefit
based
on
evidence.
